List of insiders holdings for NEXIEN BIOPHARMA INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
1 | Kanativa USA Inc. 10% Owner | 2019-05-01 19:15:07 | 19,000,000 0 | 19,000,000 | Form 4 |
2 | Kanativa Inc. 10% Owner | 2019-05-02 14:08:52 | 0 19,000,000 | 19,000,000 | Form 4 |
3 | Friedland Jeffrey Former 10% Owner | 2019-11-25 14:07:17 | 0 19,000,000 | 19,000,000 | Form 4 |
4 | Greenberg Richard S Chief Executive Officer 10% Owner | 2024-05-28 11:58:42 | 13,164,052 0 | 13,164,052 | Form 4 |
5 | Heiden Ivo CEO and Chairman 10% Owner | 2016-09-06 12:29:02 | 10,000,000 0 | 10,000,000 | Form 3/A |
6 | Wasoff Evan L Chief Financial Officer | 2024-05-28 11:57:51 | 8,620,000 0 | 8,620,000 | Form 4 |
7 | Wasyl Alexander Michael Chief Executive Officer | 2018-11-01 16:22:52 | 5,445,000 0 | 5,445,000 | Form 3 |
8 | Bankier Alain D resigning officer & director | 2019-04-03 17:20:30 | 4,018,500 0 | 4,018,500 | Form 4 |
9 | Goldfarb Robert I Chief Operating Officer | 2023-08-03 10:23:54 | 3,278,000 0 | 3,278,000 | Form 4 |
10 | Manganella Frank J VP Corporate Development | 2018-11-08 15:29:19 | 2,420,000 0 | 2,420,000 | Form 3 |
11 | Reeh Jeremy Robert VP Translational Research | 2018-11-02 17:18:00 | 1,925,000 0 | 1,925,000 | Form 3 |
12 | Aceto Joseph F VP Legal & IP Counsel | 2018-10-31 17:19:54 | 1,045,000 0 | 1,045,000 | Form 3 |
13 | Snider Lindy Director | 2021-06-07 18:00:52 | 830,000 0 | 830,000 | Form 4 |
14 | Clark Courtney Lynne Director | 2018-08-17 11:06:41 | 100,000 0 | 100,000 | Form 3 |